Huimin Zou

5PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsNutritional epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 06, 2025
Cost-effectiveness of camrelizumab plus rivoceranib versus sorafenib as first-line treatment of unresectable hepatocellular carcinoma.

Huimin Zou, Yunfeng Lai, Xianwen Chen

|Dec 16, 2024
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study.

Ying Hu, Xianwen Chen, Huimin Zou

|Apr 28, 2023
Exosome-Modified Liposomes Targeted Delivery of Thalidomide to Regulate Treg Cells for Antitumor Immunotherapy.

Yang Yang, Qingfu Wang, Huimin Zou

|Jan 08, 2023
Clinical Outcomes Associated with Monotherapy and Combination Therapy of Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Hepatocellular Carcinoma in Real-World Practice: A Systematic Literature Review and Meta-Analysis.

Huimin Zou, Qing Lei, Xin Yan

|Jan 08, 2023
Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis.

Xin Yan, Huimin Zou, Yunfeng Lai

Pageof 1

Frequent Collaborators

2 joint publications

Hao Hu

1 joint publications

Yunfeng Lai

1 joint publications

Yang Yang

1 joint publications

Xianwen Chen